Open Beta
MetriLume

US marketsOPK

SEC-sourced researchBeta

OPK

OPKO HEALTH, INC.

Company comparison ↗

Data passport

CIK
0000944809
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 863,495,000.0000 USD; December 2024: 713,142,000.0000 USD; December 2025: 606,879,000.0000 USD863.5M USD0 USD0December 2023December 2024December 2025
OPK · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023863,495,000.0000Feb 26, 2026
December 2024713,142,000.0000Feb 26, 2026
December 2025606,879,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025606,879,000.0000-225,680,000.0000-178,542,000.00001,931,944,000.0000663,985,000.0000Feb 26, 2026
December 2024713,142,000.0000-53,224,000.0000-183,489,000.00002,200,212,000.0000834,764,000.0000Feb 26, 2026
December 2023863,495,000.0000-188,863,000.0000-28,197,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$606.88MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$713.14MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$225.68MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$178.54MDecember 2025Feb 26, 202610-K
Total assetsAssets$1.93BDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$663.99MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗